Organisation paid for research Program year 2023 Source: CMS Open Payments

Argus Research

Neither a doctor nor a teaching hospital

Research payments

$254,110

56 payments

Through program year 2023, Argus Research is reported as receiving $254,110 in research payments, across 56 payments.

By program year

5 rows
Year Kind Amount Payments
2023 Research $80,050 5
2022 Research $20,400 1
2021 Research $33,160 6
2020 Research $54,411 16
2019 Research $66,090 28

Breakdown

Who paid Research payments · program years 2019–2023
  1. Carl Zeiss Meditec Cataract Technology Inc. $133,610 12 payments
  2. Glaukos Corporation $67,039 30 payments
  3. Carl Zeiss Meditec Production LLC $39,080 4 payments
  4. Allergan Inc. $11,304 4 payments
  5. Sun Pharmaceutical Industries Inc. $3,078 6 payments
Studies the money was for Research payments · program years 2019–2023
  1. A Multi-Center, Prospective Clinical Evalutation of the Safety and Effectiveness of the CT Lucia 611P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal. $39,080 4 payments
  2. A Prospective Multicenter Study To Assess The Clinical Outcomes Of Current Phacoemulsification Approach To Cataract Extraction Versus The Micor System Device Using Low Energy Lens Extraction in Patients Undergoing Cataract Surgery $37,000 2 payments
  3. iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study $36,360 3 payments
  4. A Prospective MultiCenter Study to Assess the Clinical Outcomes of Low Energy Lens Fragmentation Cataract Extraction in Patients Undergoing Cataract Surgery $20,400 1 payment
  5. A Prospective Multicenter Study To Assess The Clinical Outcomes Of Current Phacoemulsification Approach To Cataract Extraction Versus The Micor System Device Using Low Energy Lens Extraction in Patients Undergoing Cataract Surgery $16,850 1 payment
  6. A Prospective Multicenter Study To Assess The Clinical Outcomes Of Current Phacoemulsification Approach To Cataract Extraction Versus The Micor System Device Using Low Energy Lens Extraction in Patients Undergoing Cataract Surgery $16,850 1 payment
  7. A Prospective, Randomized, Single-Masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery $15,249 12 payments
  8. Prospective, Randomized Phase II Study Comparing Two Elution Rates of Glaukos Travoprost Intraocular Implants to Timolol Maleate Ophthalmic Solution, USP, 0.5 $11,415 11 payments
  9. The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension $11,304 4 payments
  10. A Prospective MultiCenter Study to Assess the Clinical Outcomes of Low Energy Lens Fragmentation Cataract Extraction in Patients Undergoing Cataract Surgery $10,240 1 payment
What the money was spent on Research payments · program years 2019–2023
  1. Other $3,078 6 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record